World Cancer Day 2026 – 1,000 MCED Tests for Early Detection

Early detection saves lives—but access must reach everyone.

In conjunction with World Cancer Day 2026, Gene Solutions Malaysia and the National Cancer Society Malaysia (NCSM) officially signed a Memorandum of Understanding (MOU), marking the soft launch of the Early4Life Campaign.

This partnership represents a shared commitment to expanding cancer awareness and improving access to early detection nationwide.

As part of this initiative, SPOT-MAS 10, an AI-powered, Multi-Cancer Early Detection (MCED) blood test, will be provided to support B40 communities through NCSM outreach programs starting this year. Designed for healthy individuals aged 40 and above, this non-invasive liquid biopsy requires only a 10 mL blood sample to screen for early cancer signals and help predict potential tumor locations.

This MOU is just the beginning. Stay tuned as we continue to roll out the Early4Life Campaign.